Research demonstrates that socioeconomic inequalities are "strong determinants" of cardiovascular risk throughout the world.
Members of the writing committee for the American College of Cardiology/American Heart Association 2019 Guideline on Primary Prevention of Cardiovascular Disease incorporated throughout the guideline consideration of how social determinants of health may impact the efficacy of specific guidance and prescriptions for an individual patient. ACC/AHA recommends that clinicians revisit these considerations at each follow-up visit.
Considerations include but are not limited to socioeconomic and educational status as well as cultural, home, and employment environments. The slides below highlight examples of considerations cited by the ACC/AHA for 7 health domains.
Social Determinants of Health and Prevention of Cardiovascular Disease
Research demonstrates that socioeconomic inequalities are "strong determinants" of cardiovascular risk throughout the world.
Members of the writing committee for the American College of Cardiology/American Heart Association 2019 Guideline on Primary Prevention of Cardiovascular Disease incorporated throughout the guideline consideration of how social determinants of health may impact the efficacy of specific guidance and prescriptions for an individual patient. ACC/AHA recommends that clinicians revisit these considerations at each follow-up visit.
Considerations include but are not limited to socioeconomic and educational status as well as cultural, home, and employment environments. The slides below highlight examples of considerations cited by the ACC/AHA for 7 health domains.
New Study Shows Men with Diabetes Have Higher Risk of Disease-related Complications than Women
May 17th 2024Men with diabetes had a greater risk of CVD, lower limb and kidney complications, and diabetic retinopathy compared to women with diabetes.
Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care
August 30th 2023Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.
Cardiovascular-Kidney-Metabolic Syndrome in the US: Daily Dose
May 16th 2024Your daily dose of the clinical news you may have missed.
Obesity & Type 2 Diabetes: An Expert Discussion
June 30th 2023In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.
Irregular Menstrual Cycle Associated with Cardiometabolic Conditions in Women Regardless of PCOS Status
May 15th 2024New research shows that menstrual irregularity is associated with a higher prevalence of cardiometabolic conditions in women, even in the absence of PCOS.
SGLT2i Use and Improved QoL, Functional Capacity in Adults With HF: Daily Dose
May 15th 2024Your daily dose of the clinical news you may have missed.
New Study Shows Men with Diabetes Have Higher Risk of Disease-related Complications than Women
May 17th 2024Men with diabetes had a greater risk of CVD, lower limb and kidney complications, and diabetic retinopathy compared to women with diabetes.
Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care
August 30th 2023Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.
Cardiovascular-Kidney-Metabolic Syndrome in the US: Daily Dose
May 16th 2024Your daily dose of the clinical news you may have missed.
Obesity & Type 2 Diabetes: An Expert Discussion
June 30th 2023In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.
Irregular Menstrual Cycle Associated with Cardiometabolic Conditions in Women Regardless of PCOS Status
May 15th 2024New research shows that menstrual irregularity is associated with a higher prevalence of cardiometabolic conditions in women, even in the absence of PCOS.
SGLT2i Use and Improved QoL, Functional Capacity in Adults With HF: Daily Dose
May 15th 2024Your daily dose of the clinical news you may have missed.